Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 5
Submit an article Journal homepage
88
Views
12
CrossRef citations to date
0
Altmetric
Original

Long-term treatment with rituximab is feasible in selected patients with B-CLL: Response-adjusted low-dose maintenance treatment with rituximab in patients with relapsed B-CLL, who achieved a partial or minimal response to prior rituximab therapy

Stefanie Srock Department of Hematology and Oncology, Charité Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany
,
Folke Schriever Hämatologisch-onkologische Praxis, 84405, Dorfen, Germany
,
Andreas Neubauer University Hospital, Marburg, Germany
,
Michael Herold Helios Klinikum Erfurt, Germany
&
Dieter Huhn Meoclinic, Friedrichstr. 71, 10117, Berlin, GermanyCorrespondence[email protected]
Pages 905-911 | Received 27 Aug 2006, Accepted 13 Jan 2007, Published online: 01 Jul 2009

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.